Congress Delays Sweeping Federal Ban On Hemp-Derived Intoxicants

Congress Extends Federal Hemp Deadline

The U.S. House of Representatives approved a continuing appropriations bill on Tuesday by a vote of 370 to 48. This one-month extension gives lawmakers additional time to address the regulatory status of intoxicating cannabinoid markets.

The delay specifically postpones the 0.4-milligram-per-container THC limit for finished products. It also suspends rules covering cannabinoids that occur naturally but are manufactured outside the plant.

However, one part of the crackdown still takes effect on November 12. Products containing cannabinoids that cannot occur naturally in the cannabis plant will immediately lose their federal hemp status. This distinction separates synthetic compounds from those that can be found in nature but are commercially converted.

Legislative Response to Market Concerns

Rep. Morgan Griffith, a Virginia Republican, stated that the delay allows for further consideration of a federal regulatory framework. He said the move “gives lawmakers additional time to consider a federal regulatory framework for intoxicating hemp-derived products.” Griffith chairs the House Energy and Commerce Subcommittee on Health and has introduced the HEMP Act.

The HEMP Act would place hemp-derived products intended for human consumption under an FDA regulatory framework. Griffith added that his bill helps establish necessary federal guardrails for the industry. He emphasized that American producers and consumers deserve a system that upholds oversight and safety.

Blain Bechtold, president of iHemp Michigan, described the extension as a small reprieve for the industry. He said, “This is certainly good news,” while noting it only provides one month of relief. Bechtold argued that the temporary extension is not a permanent solution but rather a chance for Congress to complete work on long-term policy.

Impact on CBD and Intoxicants

The original restrictions threatened conventional cannabidiol products that contain trace amounts of THC. The 0.4-milligram limit was low enough to eliminate many full-spectrum CBD wellness items that do not produce intoxicating effects. Lawmakers now have until December 11 to distinguish these non-intoxicating products from the psychoactive market.

Intoxicating products such as delta-8 THC gummies and high-THCA flower remain caught in the broader crackdown until the new date. These items are often sold through convenience stores and gas stations outside of state-regulated marijuana systems. The delay allows these producers another chance to press for federal rules instead of prohibition.

The measure now goes to President Donald Trump for signature. The federal government will be funded through December 11 under the new act. If Congress does not change the law again, the remaining restrictions will take effect on that date.

Related Stories

• Study Finds Topical CBD And Cannabis Ease Fibromyalgia Pain
• House Lawmakers Demand Clarity On Federal Medical Cannabis Framework
• Oregon Psilocybin Study Confirms Sustained Relief For Depression And Anxiety